Antero Resources has just reported its Q2 results — the print the market has been bracing for — with options positioning still heavily defensive and short interest nudging higher after weeks of decline.
The clearest tension heading into the release was in options. The put/call ratio closed Tuesday at 2.03, still well above its 20-day average of 1.57 and running nearly 1.7 standard deviations elevated. That is a continuation of the cautious stance noted in the pre-earnings piece published Sunday — the PCR jumped from around 1.30 in mid-July and has held above 2.0 for most of the past week. Options traders were not expecting a smooth ride. The borrow market remains a complete contrast: availability is extraordinary loose at over 5,600%, meaning there are roughly 56 shares available to borrow for every one currently shorted, and borrowing costs are running at just 0.38% — down roughly 9% over the past week and 31% over the past month. The lending pool tells a story of almost zero squeeze risk.
Short interest, however, has started to tick back up after its dramatic collapse. The prior piece noted shorts had cut exposure by nearly 28% over the previous month, reaching 3.3% of the free float. That decline has paused. Short interest rose 4% on Tuesday alone and is up 10% on the week, pulling back to 3.5% of the float. In absolute terms the position is still less than half what it was in late June, when bears held roughly 14 million shares. But the direction has shifted — bears are rebuilding modestly, even as the earnings tape is printing.
The analyst community is broadly constructive but has spent the past month cutting price targets. UBS trimmed to $50 from $56 on July 14, Truist cut to $52 from $56 on July 9, and JPMorgan lowered its Neutral target to $45 from $49 earlier in the month. Goldman Sachs and Morgan Stanley both trimmed targets in late June. The mean target across the Street is $48.25, roughly 42% above the current price of $33.88 — a wide implied return, though those targets have been drifting lower. On valuation the stock trades at 8.3x earnings and 5.1x EV/EBITDA, both modest multiples for an E&P name. The EPS surprise factor score ranks in the 82nd percentile, suggesting the company has a strong track record of beating estimates — relevant context with results now in.
Among peers, RRC added 1% on the day and 1.4% on the week, while EQT slipped fractionally but is up 3.7% over the same period. CRK stands out on the downside, falling nearly 5% Tuesday and down 6.8% on the week — a notable divergence within the Appalachian natural gas group. AR's flat week (+0.06%) and fractionally positive Tuesday (+0.09%) place it in the middle of the peer pack.
Institutional ownership adds one notable data point. Invesco added over 4 million shares in the most recently reported quarter, the largest incremental change among the top 15 holders, lifting its position to 2.75% of shares. BlackRock and State Street both added meaningfully as well. Founder-linked entity Paul Rady, however, cut holdings by nearly 5.8 million shares as of April 13 — a reduction worth watching for context on long-term conviction from the company's inner circle.
With results now on the table, the key watch is whether the defensive options positioning unwinds quickly — a PCR returning toward its 20-day average would signal the market absorbing the print comfortably — or whether bears use the post-earnings window to rebuild the short interest that has quietly begun reaccumulating this week.
See the live data behind this article on ORTEX.
Open AR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
